Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
about
Non-hormonal interventions for hot flushes in women with a history of breast cancerComparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses.Effect of Expressive Writing Intervention on Health Outcomes in Breast Cancer Patients: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsLifestyle Factors in Cancer Survivorship: Where We Are and Where We Are HeadedGeographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.Adjuvant therapy use among Appalachian breast cancer survivorsCognitive behavioural treatment for women who have menopausal symptoms after breast cancer treatment (MENOS 1): a randomised controlled trial.The development and acceptability of symptom management quality improvement reports based on patient-reported data: an overview of methods used in PROSSES.Musculoskeletal adverse events associated with adjuvant aromatase inhibitors.Early discontinuation of adjuvant hormone therapy is associated with a poor prognosis in Japanese breast cancer patients.Exercise in clinical cancer care: a call to action and program development description.Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.Breast cancer survivorship issues.Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: study protocol of a randomized controlled trialThe impact of age on changes in quality of life among breast cancer survivors treated with breast-conserving surgery and radiotherapySisters Peer Counseling in Reproductive Issues After Treatment (SPIRIT): a peer counseling program to improve reproductive health among African American breast cancer survivorsBreast cancer medications and vision: effects of treatments for early-stage disease.A pilot study of website information regarding aromatase inhibitors: dietary supplement interactionsLong-term psychological benefits of cognitive-behavioral stress management for women with breast cancer: 11-year follow-up of a randomized controlled trial.Better exercise adherence after treatment for cancer (BEAT Cancer) study: rationale, design, and methods.Role of the general practitioner during the active breast cancer treatment phase: an analysis of health care use.Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Long-term assessment of quality of life in the Intergroup Exemestane Study: 5 years post-randomisation.Validity and reliability of the Patient-Reported Arthralgia Inventory: validation of a newly-developed survey instrument to measure arthralgia.Sexual function in breast cancer patients: a prospective study from Iran.Relationship between deficits in overall quality of life and non-small-cell lung cancer survivalSymptoms and Symptom Attribution Among Women on Endocrine Therapy for Breast Cancer.Hot flashes: the ongoing search for effective interventions.Contemporary quality of life issues affecting gynecologic cancer survivors.Menopausal symptoms in breast cancer survivors: management updateTrends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review.Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort.Breast cancer in young women and its impact on reproductive functionAntihormonal treatment associated musculoskeletal pain in women with breast cancer in the adjuvant settingA review of the use of exemestane in early breast cancer.Oncology providers' perspectives on endocrine therapy prescribing and management.Vaginal Estrogen Therapy for Patients with Breast Cancer.A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivorsPhysical Activity and Breast Cancer: A Qualitative Study on the Barriers to and Facilitators of Exercise Promotion from the Perspective of Health Care Professionals.
P2860
Q24235391-96B0D348-53D7-4385-BD30-A7E14B8A1F12Q26797380-5AA62289-CAD0-48B3-936E-39417CA29689Q26853050-2A17E5F3-70D7-4FF1-AD74-B2A91567DCD5Q27011454-72B86428-E651-4736-ACB6-375BF8A72749Q30275906-FE7AEA20-F011-404C-9EAD-1CFAF30AF00AQ30279083-64F9167E-915D-4B47-91D2-7A5B8F68C143Q30512236-D8FF0EA3-A162-4058-909A-79C0D26AD230Q31110331-52FA00D3-F3BA-46B8-9455-205D774FF5AEQ34143532-EB613CC9-F3D4-4946-8FB6-2E6EAB310B20Q34174599-63FD5522-C6B7-4959-93A2-1926158C9E93Q34293790-645276D2-8C84-4FA7-85DA-1BFB455F589AQ34818002-B9C155EF-222C-4508-9D15-4A2A761C7503Q34895561-90C4C106-5CF7-497A-B764-EF0726B7D67BQ34991931-B5BBA9B5-FB99-4C71-B533-509EEC907371Q35098307-A08B1615-26C6-4E68-A22D-74D150DDE8DEQ35166915-396B2B21-4C87-4A9F-8A73-0714DBB0678BQ35496778-D89996FA-F42F-48EE-B740-7D4486526618Q35565585-F056A4B3-B78B-4FB6-AB11-9C66655A7FCEQ35637388-232141A1-7EAC-49EB-A864-B0BD67D08AC9Q35661099-D92AEDB9-54CE-4945-B79E-685A9F4A8132Q35815687-AF0D0F88-F0DF-4798-A40D-9355E4B6FCEBQ35824414-6DD64B44-5DC9-4145-BDB9-C27BAF0135A4Q35832316-039A6E08-B8F9-42F5-88B6-CFB97883BCC2Q35914925-A4F8CE32-0520-4A2F-92B2-D4E9E60CEB0DQ35950964-EE6152FB-7F48-483D-83E0-3D5EE2E3AB2BQ36058286-AD8799BA-903C-4762-BCB3-FC3A1A859799Q36064866-2630A022-4AC3-434B-A6FE-17303C1ABB24Q36067687-2BF4FDCD-4369-4715-938C-38AFC1119CEAQ36067725-8B4AEF87-2121-42BE-9AA9-22D0AFE1B44BQ36485849-7464E955-7E9F-4245-9FB3-FEB3304F3CD4Q36487328-6FE8332D-B1E4-4B7D-B94F-5E190E1473E3Q36713559-0A3C1F24-DBBB-44B6-B625-0DDB8E83483BQ36941450-12CCE15A-EBDD-48F1-BFB6-2B96F5145A39Q37153908-9636BDBD-5CBC-4F01-89B9-ED7B52D12D70Q37174823-023A8BFA-6CAE-412D-9EA1-835CAA466DA7Q37230265-A659BF5F-2506-4465-9E6D-4733B2C4CAA0Q37316792-7FEDD08D-990E-4B9F-BECB-9BD47C0B24E6Q37389691-B14BE7ED-BA60-43D8-848E-40382353D201Q37421894-8F9C924C-982B-47A6-8BAD-1DD90A1C8A76Q37445895-D109C851-576B-4FAE-8D38-FC6961C2150E
P2860
Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Recognition and management of ...... ng adjuvant endocrine therapy.
@en
type
label
Recognition and management of ...... ng adjuvant endocrine therapy.
@en
prefLabel
Recognition and management of ...... ng adjuvant endocrine therapy.
@en
P2860
P1476
Recognition and management of ...... ng adjuvant endocrine therapy.
@en
P2093
David Cella
P2860
P2888
P304
P356
10.1007/S10549-007-9548-1
P407
P577
2007-09-18T00:00:00Z